Cargando…

Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA

BACKGROUND: MicroRNAs biomarkers have shown value for diagnosis and prognosis of various cancers. Combination with established tumor markers has rarely been done. RESULTS: Breast cancer patients had significantly higher serum RNA loads (AUC 0.665), lower miR-34a (AUC 0.772), higher CEA and CA 15-3 l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaleski, Martin, Kobilay, Makbule, Schroeder, Lars, Debald, Manuel, Semaan, Alexander, Hettwer, Karina, Uhlig, Steffen, Kuhn, Walther, Hartmann, Gunther, Holdenrieder, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976482/ https://www.ncbi.nlm.nih.gov/pubmed/29854296 http://dx.doi.org/10.18632/oncotarget.25077

Ejemplares similares

Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer
por: Dohmen, Jonas, et al.
Publicado: (2022)

Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis
por: Holdenrieder, Stefan, et al.
Publicado: (2017)

Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies
por: Schröder, Lars, et al.
Publicado: (2023)

Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
por: Ebeling, F G, et al.
Publicado: (2002)

Challenges in breast cancer management and prevention
por: Debald, Manuel, et al.
Publicado: (2014)

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
por: Nicolini, Andrea, et al.
Publicado: (2006)

Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
por: Ginguay, Antonin, et al.
Publicado: (2022)

Diagnostic impact of CEA and CA 15-3 on chemotherapy monitoring of breast cancer patients
por: Hasan, Diya
Publicado: (2022)

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
por: Bartsch, Rupert, et al.
Publicado: (2006)

Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer
por: Zhao, Wenjing, et al.
Publicado: (2021)

Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer
por: Wang, Gangping, et al.
Publicado: (2014)

Diagnostic Utility of Combined CEA, CA15-3 and CA125 Biomarkers and Cytomorphology in Suspicious and Malignant Serosal Fluid
por: Rahemi, Zahra, et al.
Publicado: (2021)

Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C
por: ASSMAR, Mehdi, et al.
Publicado: (2016)

Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer
por: Wu, San-Gang, et al.
Publicado: (2016)

Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology
por: Diaz, Inga Medina, et al.
Publicado: (2023)

Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer
por: Kristiansen, Søren, et al.
Publicado: (2015)

Longitudinal Evaluation of AFP and CEA External Proficiency Testing Reveals Need for Method Harmonization
por: Wojtalewicz, Nathalie, et al.
Publicado: (2023)

Menstrual Cycle Dependent Variability for Serum Tumor Markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in Healthy Women
por: Erbağci, Ayşe Binnur, et al.
Publicado: (1999)

Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients
por: Dai, Danian, et al.
Publicado: (2016)

Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
por: Fan, Yuying, et al.
Publicado: (2021)

Non-invasive proteomics—thinking about personalized breast cancer screening and treatment
por: Debald, Manuel, et al.
Publicado: (2010)

Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance
por: Hing, J.X., et al.
Publicado: (2020)

Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
por: Nicolini, A., et al.
Publicado: (1991)

Carbon Nanopowder-Based Stochastic Sensor for Ultrasensitive Assay of CA 15-3, CEA and HER2 in Whole Blood
por: Stefan-van Staden, Raluca-Ioana, et al.
Publicado: (2022)

FTO, PIK3CB serve as potential markers to complement CEA and CA15-3 for the diagnosis of breast cancer
por: Mi, Jintao, et al.
Publicado: (2023)

Preoperative serum levels of CEA and CA 242 in colorectal cancer.
por: Carpelan-Holmström, M., et al.
Publicado: (1995)

The Clinical Significance of CEA, CA19–9, and CA125 in Management of Appendiceal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Real-Time PCR Assay for the Detection and Quantification of Roe Deer to Detect Food Adulteration—Interlaboratory Validation Involving Laboratories in Austria, Germany, and Switzerland
por: Druml, Barbara, et al.
Publicado: (2021)

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
por: Shao, Yingbo, et al.
Publicado: (2015)

‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention
por: Debald, Manuel, et al.
Publicado: (2013)

Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge
por: Zhao, Song, et al.
Publicado: (2016)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
por: Lakemeyer, Leilani, et al.
Publicado: (2021)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis
por: Fu, Yijie, et al.
Publicado: (2016)

Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9.
por: Nilsson, O., et al.
Publicado: (1992)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.
por: Hall, N. R., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_jrdrp8ci651irb3oi5i2q7j23d